Oct 24,2023
OBiO Announces Strategic Partnership with Refreshgene to Realize Commercialization of Gene Therapy Product
OBiO Technology (Shanghai) Corp., Ltd. (Stock code: SH688238), a world leading contract development and manufacturing organization for cell and gene therapy, officially announced an agreement with Refreshgene Therapeutics (Refreshgene).